Can fite biopharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Can fite biopharma Contact Number

Israeli Office. 10 Bareket Street Kiryat Matalon P.O. Box 7537 Petah-Tikva 49170 ISRAEL ()Tel: +972-3-9241114 Fax: +972-3-9249378 General email: [email protected]

Contact US: http://www.canfite.com/?KPageId=26

Development

25 People Used

See More ››

Can Fite BioPharma

Can-Fite BioPharma (NYSE American: CANF TASE:CFBI) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The Company has an advanced pipeline of proprietary drug candidates in Phase II and III clinical development which address inflammatory, liver and metabolic diseases.

View Contact ››

Download

28 People Used

See More ››

Can Fite BioPharm (NYSE American: CANF)

Download Fact Sheet For more information on Can-Fite BioPharm, contact RedChip specialists at: 1-800-REDCHIP (733-2447) Advanced Stage Drug Maker in Multi-Billion Dollar Market Receives Buy Rating & $7 Price Target from Dawson James (as of September 11, 2019) CanFite unveils Phase III Clinical Trial Programs and Strategic Partnerships

View Contact ››

Contact

61 People Used

See More ››

CanFite BioPharma

Contact Email [email protected] Phone Number +97239241114 Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.

View Contact ››

BioPharma

55 People Used

See More ››

Can Fite BioPharma

Contact; Can-Fite BioPharma admin 2021-02-22T14:31:08-05:00. Can-Fite BioPharma Muscles Don’t Get Cancer. estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking

View Contact ››

Including

86 People Used

See More ››

Phone: 972 3 924 1114 http://www.canfite.com Company

including anti-inflammatory effects and reduced liver fat content. Can-Fite is now preparing a Phase IIb study in NASH, with manufacturing of the drug supply complete. NASH is an unmet medical need projected to become a $35-$40 billion market by 2025. Investor Contact

View Contact ››

People

49 People Used

See More ››

Can Fite BioPharma Ltd.

Contact Can-Fite BioPharma Ltd. on Messenger. www.canfite.com. Biotechnology Company. Page Transparency See More. Facebook is showing information to help you better understand the purpose of a Page. See actions taken by the people who manage and post content. Page created - December 11, 2017. People. 48 likes.

View Contact ››

Quarter

42 People Used

See More ››

Can Fite BioPharma Company Profile

Can-Fite BioPharma has 248 Twitter Followers. The number of followers has increased 4.4% month over month and increased 19.3% quarter over quarter

View Contact ››

Please leave your comments here:

Popular Brands

Cnooc
Cae
Cerner
Csi